Colorado 2023 Regular Session

Colorado Senate Bill SB144 Compare Versions

OldNewDifferences
1+First Regular Session
2+Seventy-fourth General Assembly
3+STATE OF COLORADO
4+REREVISED
5+This Version Includes All Amendments
6+Adopted in the Second House
7+LLS NO. 23-0797.01 Kristen Forrestal x4217
18 SENATE BILL 23-144
2-BY SENATOR(S) Ginal, Marchman, Buckner, Fields, Gardner, Kirkmeyer,
3-Liston, Lundeen, Pelton R., Rich, Smallwood, Will, Zenzinger;
4-also REPRESENTATIVE(S) Mabrey and Young, Bacon, Bird,
5-Boesenecker, Duran, Epps, Froelich, Garcia, Gonzales-Gutierrez, Hamrick,
6-Herod, Jodeh, Joseph, Kipp, Lieder, Lindsay, Ortiz, Parenti, Snyder, Story,
7-Titone, Velasco, Willford.
9+Senate Committees House Committees
10+Health & Human Services Health & Insurance
11+A BILL FOR AN ACT
812 C
9-ONCERNING PRESCRIPTION DRUGS FOR THE TREATMENT OF CHRONIC PAIN .
10-Be it enacted by the General Assembly of the State of Colorado:
11-SECTION 1. In Colorado Revised Statutes, add 12-30-109.5 as
12-follows:
13-12-30-109.5. Prescription drugs for treatment of chronic pain -
14-patients - prescribers - definitions. (1) A
15-S USED IN THIS SECTION, UNLESS
16-THE CONTEXT OTHERWISE REQUIRES
17-:
13+ONCERNING PRESCRIPTION DRUGS FOR THE TREATMENT OF CHRONIC101
14+PAIN.102
15+Bill Summary
16+(Note: This summary applies to this bill as introduced and does
17+not reflect any amendments that may be subsequently adopted. If this bill
18+passes third reading in the house of introduction, a bill summary that
19+applies to the reengrossed version of this bill will be available at
20+http://leg.colorado.gov
21+.)
22+The bill allows a health-care provider to prescribe, dispense, or
23+administer a schedule II, III, IV, or V controlled substance (drug) to a
24+patient in the course of treatment for a diagnosed condition that causes
25+chronic pain. The bill also clarifies that the prescribing health-care
26+provider is not subject to disciplinary action by the appropriate regulator
27+for prescribing a dosage of a drug that is equal to or more than a
28+HOUSE
29+3rd Reading Unamended
30+April 13, 2023
31+HOUSE
32+Amended 2nd Reading
33+April 12, 2023
34+SENATE
35+3rd Reading Unamended
36+March 9, 2023
37+SENATE
38+Amended 2nd Reading
39+March 7, 2023
40+SENATE SPONSORSHIP
41+Ginal, Marchman, Buckner, Fields, Gardner, Kirkmeyer, Liston, Lundeen, Pelton R., Rich,
42+Smallwood, Van Winkle, Will, Zenzinger
43+HOUSE SPONSORSHIP
44+Mabrey and Young, Bacon, Bird, Boesenecker, Duran, Epps, Froelich, Garcia, Gonzales-
45+Gutierrez, Hamrick, Herod, Jodeh, Joseph, Kipp, Lieder, Lindsay, Ortiz, Parenti, Snyder,
46+Story, Titone, Velasco, Willford
47+Shading denotes HOUSE amendment. Double underlining denotes SENATE amendment.
48+Capital letters or bold & italic numbers indicate new material to be added to existing law.
49+Dashes through the words or numbers indicate deletions from existing law. morphine milligram equivalent dosage recommendation or threshold
50+specified in state or federal opioid prescribing guidelines or policies.
51+The bill prohibits a health-care provider from refusing to accept or
52+continue to treat a patient solely on the basis of the dosage of a drug the
53+patient requires for the treatment of chronic pain. A health-care provider
54+is also prohibited from tapering a needed dosage solely to meet a
55+predetermined dosage recommendation.
56+The bill also prohibits a pharmacist, health insurance carrier, or
57+pharmacy benefit manager from refusing to fill or approve the coverage
58+for a drug solely on the basis of the dosage requirement of a patient.
59+Be it enacted by the General Assembly of the State of Colorado:1
60+SECTION 1. In Colorado Revised Statutes, add 12-30-109.5 as2
61+follows:3
62+12-30-109.5. Prescription drugs for treatment of chronic pain4
63+- patients - prescribers - definitions. (1) A
64+S USED IN THIS SECTION,5
65+UNLESS THE CONTEXT OTHERWISE REQUIRES :6
1866 (a) "C
19-ARRIER" HAS THE SAME MEANING AS SET FORTH IN 10-16-102
20-(8).
67+ARRIER" HAS THE SAME MEANING AS SET FORTH IN7
68+10-16-102
69+ (8).8
2170 (b) (I) "C
22-HRONIC PAIN" MEANS A PAIN THAT TYPICALLY LASTS THREE
23-NOTE: This bill has been prepared for the signatures of the appropriate legislative
24-officers and the Governor. To determine whether the Governor has signed the bill
25-or taken other action on it, please consult the legislative status sheet, the legislative
26-history, or the Session Laws.
27-________
28-Capital letters or bold & italic numbers indicate new material added to existing law; dashes
29-through words or numbers indicate deletions from existing law and such material is not part of
30-the act. MONTHS OR LONGER AND MAY BE THE RESULT OF AN UNDERLYING MEDICAL
31-DISEASE OR CONDITION
32-, INJURY, MEDICAL TREATMENT, INFLAMMATION, OR
33-UNKNOWN CAUSE
34-. "CHRONIC PAIN" IS A PAIN STATE IN WHICH THE CAUSE OF
35-THE PAIN OFTEN CANNOT BE REMOVED WITH REAS ONABLE MEDICAL EFFORTS
36-AT THE CONSENT OF THE PATIENT
37-, OR PAIN FOR WHICH NO CURE CAN BE
38-FOUND AFTER REASONABLE MEDICAL EFFORTS
39-. CHRONIC PAIN MAY RESTRICT
40-THE ABILITY OF INDIVIDUALS TO WORK
41-, CARE FOR THEMSELVES , AND
42-ENGAGE IN BASIC LIFE
43-, SOCIAL, AND PHYSICAL ACTIVITIES.
71+HRONIC PAIN" MEANS A PAIN THAT TYPICALLY LASTS
72+9
73+THREE MONTHS OR LONGER AND MAY BE THE RESULT OF AN UNDERLYING10
74+MEDICAL DISEASE OR CONDITION , INJURY, MEDICAL TREATMENT ,11
75+INFLAMMATION, OR UNKNOWN CAUSE. "CHRONIC PAIN" IS A PAIN STATE12
76+IN WHICH THE CAUSE OF THE PAIN OFTEN CANNOT BE REMOVED WITH13
77+REASONABLE MEDICAL EFFORTS AT THE CONSENT OF THE PATIENT , OR PAIN14
78+FOR WHICH NO CURE CAN BE FOUND AFTER REASONABLE MEDICAL15
79+EFFORTS. CHRONIC PAIN MAY RESTRICT THE ABILITY OF INDIVIDUALS TO16
80+WORK, CARE FOR THEMSELVES, AND ENGAGE IN BASIC LIFE, SOCIAL, AND17
81+PHYSICAL ACTIVITIES.18
4482 (II) C
45-ONDITIONS ASSOCIATED WITH CHRONIC PAIN MAY INCLUDE ,
46-BUT ARE NOT LIMITED TO, CANCER AND THE RECOVERY PERIOD, SICKLE CELL
47-DISEASE
48-, NONCANCER PAIN, RARE DISEASES, SEVERE INJURIES, AND HEALTH
49-CONDITIONS REQUIRING THE PROVISION OF PALLIATIVE CARE OR HOSPICE
50-CARE
51-.
83+ONDITIONS ASSOCIATED WITH CHRONIC PAIN MAY INCLUDE ,19
84+BUT ARE NOT LIMITED TO, CANCER AND THE RECOVERY PERIOD , SICKLE20
85+144-2- CELL DISEASE, NONCANCER PAIN, RARE DISEASES, SEVERE INJURIES, AND1
86+HEALTH CONDITIONS REQUIRING THE PROVISION OF PALLIATIVE CARE OR2
87+HOSPICE CARE.3
5288 (III) R
53-EASONABLE EFFORTS FOR RELIEVING OR CURING THE CAUSE OF
54-THE CHRONIC PAIN MAY BE DETERMINED ON THE BASIS OF
55-, BUT ARE NOT
56-LIMITED TO
57-, THE FOLLOWING:
89+EASONABLE EFFORTS FOR RELIEVING OR CURING THE CAUSE4
90+OF THE CHRONIC PAIN MAY BE DETERMINED ON THE BASIS OF , BUT ARE NOT5
91+LIMITED TO, THE FOLLOWING:6
5892 (A) W
59-HEN TREATING A NONTERMINALLY ILL PATIENT FOR CHRONIC
60-PAIN
61-, AN EVALUATION CONDUCTED BY THE TREATING HEALTH -CARE
62-PROVIDER OR A HEALTH
63--CARE PROVIDER SPECIALIZING IN PAIN MEDICINE OR
64-TREATMENT OF THE AREA
65-, SYSTEM, OR ORGAN OF THE BODY CONFIRMED OR
66-PERCEIVED AS THE SOURCE OF THE CHRONIC PAIN
67-; OR
68-(B) WHEN TREATING A TERMINALLY ILL PATIENT , AN EVALUATION
69-CONDUCTED BY THE TREATING HEALTH
70--CARE PROVIDER WHO CONDUCTS THE
71-EVALUATION IN ACCORDANCE WITH THE STANDARD OF CARE AND THE LEVEL
72-OF CARE
73-, SKILL, AND TREATMENT THAT WOULD BE RECOGNIZED BY A
74-HEALTH
75--CARE PROVIDER UNDER SIMILAR CONDITIONS AND CIRCUMSTANCES .
93+HEN TREATING A NONTERMINALLY ILL PATIENT FOR CHRONIC7
94+PAIN, AN EVALUATION CONDUCTED BY THE TREATING HEALTH -CARE8
95+PROVIDER OR A HEALTH-CARE PROVIDER SPECIALIZING IN PAIN MEDICINE9
96+OR TREATMENT OF THE AREA , SYSTEM, OR ORGAN OF THE BODY10
97+CONFIRMED OR PERCEIVED AS THE SOURCE OF THE CHRONIC PAIN ; OR11
98+(B) W
99+HEN TREATING A TERMINALLY ILL PATIENT, AN EVALUATION12
100+CONDUCTED BY THE TREATING HEALTH -CARE PROVIDER WHO CONDUCTS13
101+THE EVALUATION IN ACCORDANCE WITH THE STANDARD OF CARE AND THE14
102+LEVEL OF CARE, SKILL, AND TREATMENT THAT WOULD BE RECOGNIZED BY15
103+A HEALTH-CARE PROVIDER UNDER SIMILAR CONDITIONS AND16
104+CIRCUMSTANCES.17
76105 (c) "D
77-RUG DIVERSION" MEANS THE UNLAWFUL TRANSFER OF
78-PRESCRIPTION DRUGS FROM A LICIT MEDICAL PURPOSE TO THE ILLICIT
79-MARKETPLACE
80-.
106+RUG DIVERSION" MEANS THE UNLAWFUL TRANSFER OF18
107+PRESCRIPTION DRUGS FROM A LICIT MEDICAL PURPOSE TO THE ILLICIT19
108+MARKETPLACE.20
81109 (d) "H
82-EALTH-CARE PROVIDER" MEANS A PHYSICIAN, A PHYSICIAN
83-ASSISTANT
84-, OR AN ADVANCED PRACTICE REGISTERED NURSE LICENSED
85-PURSUANT TO THIS TITLE
86-12.
87-(e) "R
88-ARE DISEASE" MEANS A DISEASE, DISORDER, OR CONDITION
89-PAGE 2-SENATE BILL 23-144 THAT AFFECTS FEWER THAN TWO HUNDRED THOUSAND INDIVIDUALS IN THE
90-UNITED STATES AND IS CHRONIC , SERIOUS, LIFE-ALTERING, OR
91-LIFE
92--THREATENING.
93-(f) "S
94-CHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE" MEANS A
95-CONTROLLED SUBSTANCE AS DESCRIBED IN SECTION
96-18-18-204, 18-18-205,
97-18-18-206,
98- OR 18-18-207, RESPECTIVELY.
99-(2) Criteria for the evaluation and treatment of chronic pain.
110+EALTH-CARE PROVIDER" MEANS A PHYSICIAN, A PHYSICIAN21
111+ASSISTANT, OR AN ADVANCED PRACTICE REGISTERED NURSE LICENSED22
112+PURSUANT TO THIS TITLE 12.23
113+
114+24
115+(e) "RARE DISEASE" MEANS A DISEASE, DISORDER, OR CONDITION25
116+THAT AFFECTS FEWER THAN TWO HUNDRED THOUSAND INDIVIDUALS IN26
117+THE UNITED STATES AND IS CHRONIC, SERIOUS, LIFE-ALTERING, OR27
118+144
119+-3- LIFE-THREATENING.1
120+(f) "SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE" MEANS2
121+A CONTROLLED SUBSTANCE AS DESCRIBED IN SECTION 18-18-204,3
122+18-18-205,
123+ 18-18-206, OR 18-18-207, RESPECTIVELY.4
124+(2) Criteria for the evaluation and treatment of chronic pain.5
100125 W
101-HEN TREATING A NONTERMINALLY ILL PATIENT , THE EVALUATION OF THE
102-PATIENT AND THE TREATMENT OF THE PATIENT
103-'S CHRONIC PAIN IS GOVERNED
104-BY THE FOLLOWING CRITERIA
105-:
126+HEN TREATING A NONTERMINALLY ILL PATIENT , THE EVALUATION OF6
127+THE PATIENT AND THE TREATMENT OF THE PATIENT 'S CHRONIC PAIN IS7
128+GOVERNED BY THE FOLLOWING CRITERIA :8
106129 (a) A
107- DIAGNOSIS OF A CONDITION CAUSING CHRONIC PAIN BY THE
108-TREATING HEALTH
109--CARE PROVIDER OR A HEALTH -CARE PROVIDER
110-SPECIALIZING IN PAIN MEDICINE OR TREATMENT OF THE AREA
111-, SYSTEM, OR
112-ORGAN OF THE BODY CONFIRMED OR PERCEIVED AS THE SOURCE OF THE PAIN
113-THAT IS SUFFICIENT TO MEET THE DEFINITION OF CHRONIC PAIN
114-; AND
115-(b) THE CAUSE OF THE DIAGNOSIS OF CHRONIC PAIN MUST NOT
116-INTERFERE WITH MEDICALLY NECESSARY TREATMENT
117-, INCLUDING BUT NOT
118-LIMITED TO PRESCRIBING OR ADMINISTERING A SCHEDULE
119-II, III, IV, OR V
120-CONTROLLED SUBSTANCE .
121-(3) Prescription and administration of controlled substances for
122-chronic pain. (a) N
123-OTWITHSTANDING ANY OTHER PROVISION OF LAW , A
124-HEALTH
125--CARE PROVIDER MAY PRESCRIBE , DISPENSE, OR ADMINISTER A
126-SCHEDULE
127-II, III, IV, OR V CONTROLLED SUBSTANCE TO A PATIENT IN THE
128-COURSE OF THE HEALTH
129--CARE PROVIDER'S TREATMENT OF THE PATIENT FOR
130-A DIAGNOSED CONDITION CAUSING CHRONIC PAIN
131-. A HEALTH-CARE
132-PROVIDER IS NOT SUBJECT TO DISCIPLINARY ACTION BY THE REGULATOR FOR
133-APPROPRIATELY PRESCRIBING
134-, DISPENSING, OR ADMINISTERING A SCHEDULE
135-II, III, IV, OR V CONTROLLED SUBSTANCE IN THE COURSE OF TREATMENT OF
136-A PATIENT FOR CHRONIC PAIN IF THE HEALTH
137--CARE PROVIDER KEEPS
138-ACCURATE RECORDS OF THE PURPOSE
139-, USE, PRESCRIPTION, AND DISPOSAL OF
140-THE CONTROLLED SUBSTANCE
141-, WRITES ACCURATE PRESCRIPTIONS , AND
142-PRESCRIBES MEDICATIONS IN ACCORDANCE WITH LEGITIMATE MEDICAL
143-PURPOSE IN THE USUAL COURSE OF PROFESSIONAL PRACTICE
144-.
130+ DIAGNOSIS OF A CONDITION CAUSING CHRONIC PAIN BY THE9
131+TREATING HEALTH-CARE PROVIDER OR A HEALTH -CARE PROVIDER10
132+SPECIALIZING IN PAIN MEDICINE OR TREATMENT OF THE AREA , SYSTEM, OR11
133+ORGAN OF THE BODY CONFIRMED OR PERCEIVED AS THE SOURCE OF THE12
134+PAIN THAT IS SUFFICIENT TO MEET THE DEFINITION OF CHRONIC PAIN; AND13
135+(b) T
136+HE CAUSE OF THE DIAGNOSIS OF CHRONIC PAIN MUST NOT14
137+INTERFERE WITH MEDICALLY NECESSARY TREATMENT , INCLUDING BUT15
138+NOT LIMITED TO PRESCRIBING OR ADMINISTERING A SCHEDULE II, III, IV,16
139+OR V CONTROLLED SUBSTANCE.17
140+(3) Prescription and administration of controlled substances18
141+for chronic pain. (a) N
142+OTWITHSTANDING ANY OTHER PROVISION OF LAW ,19
143+A HEALTH-CARE PROVIDER MAY PRESCRIBE , DISPENSE, OR ADMINISTER A20
144+SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE TO A PATIENT IN THE21
145+COURSE OF THE HEALTH-CARE PROVIDER'S TREATMENT OF THE PATIENT22
146+FOR A DIAGNOSED CONDITION CAUSING CHRONIC PAIN . A HEALTH-CARE23
147+PROVIDER IS NOT SUBJECT TO DISCIPLINARY ACTION BY THE REGULATOR24
148+FOR APPROPRIATELY PRESCRIBING , DISPENSING, OR ADMINISTERING A25
149+SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE IN THE COURSE OF26
150+TREATMENT OF A PATIENT FOR CHRONIC PAIN IF THE HEALTH -CARE27
151+144
152+-4- PROVIDER KEEPS ACCURATE RECORDS OF THE PURPOSE , USE,1
153+PRESCRIPTION, AND DISPOSAL OF THE CONTROLLED SUBSTANCE , WRITES2
154+ACCURATE PRESCRIPTIONS , AND PRESCRIBES MEDICATIONS IN3
155+ACCORDANCE WITH LEGITIMATE MEDICAL PURPOSE IN THE USUAL COURSE 4
156+OF PROFESSIONAL PRACTICE.5
145157 (b) A
146- HEALTH-CARE PROVIDER ACTING IN GOOD FAITH AND BASED ON
147-PAGE 3-SENATE BILL 23-144 THE NEEDS OF THE PATIENT WITH A DIAGNOSED CONDITION CAUSING
148-CHRONIC PAIN IS NOT SUBJECT TO DISCIPLINE FROM THE REGULATOR SOLELY
149-FOR PRESCRIBING A DOSAGE THAT EQUATES TO AN UPWARD DEVIATION FROM
150-MORPHINE MILLIGRAM EQUIVALENT DOSAGE RECOMMENDATIONS OR FROM
151-THRESHOLDS SPECIFIED IN STATE OR FEDERAL OPIOID PRESCRIBING
152-GUIDELINES OR POLICIES
153-.
158+ HEALTH-CARE PROVIDER ACTING IN GOOD FAITH AND BASED6
159+ON THE NEEDS OF THE PATIENT WITH A DIAGNOSED CONDITION CAUSING7
160+CHRONIC PAIN IS NOT SUBJECT TO DISCIPLINE FROM THE REGULATOR8
161+SOLELY FOR PRESCRIBING A DOSAGE THAT EQUATES TO AN UPWARD9
162+DEVIATION FROM MORPHINE MILLIGRAM EQUIVALENT DOSAGE10
163+RECOMMENDATIONS OR FROM THRESHOLDS SPECIFIED IN STATE OR11
164+FEDERAL OPIOID PRESCRIBING GUIDELINES OR POLICIES .12
165+
166+13
154167 (c) A
155168 HEALTH-CARE PROVIDER TREATING A PATIENT WITH CHRONIC
156-PAIN BY PRESCRIBING
157-, DISPENSING, OR ADMINISTERING ONE OR MORE
158-SCHEDULE
159-II, III, IV, OR V CONTROLLED SUBSTANCES THAT INCLUDE , BUT
160-ARE NOT LIMITED TO
161-, OPIOID ANALGESICS SHALL NOT BE REQUIRED TO TAPER
162-A PATIENT
163-'S MEDICATION DOSAGE SOLELY TO MEET A PREDETERMINED
164-MORPHINE MILLIGRAM EQUIVALENT DOSAGE RECOMMENDATION OR
165-THRESHOLD IF THE PATIENT IS STABLE AND COMPLIANT WITH THE
166-TREATMENT PLAN AND IS NOT EXPERIENCING SERIOUS HARM FROM THE
167-LEVEL OF MEDICATION CURRENTLY BEING PRESCRIBED OR PREVIOUSLY
168-PRESCRIBED
169-. A DECISION TO TAPER OR MAINTAIN MEDICATION MUST
170-INCLUDE AN INDIVIDUALIZED ASSESSMENT OF THE PATIENT
171-'S CURRENT
172-MEDICAL CONDITION AND TREATMENT PLAN
173-, THE RISKS AND BENEFITS OF
174-MAINTAINING OR TAPERING THE PATIENT
175-'S MEDICATION, AND A DISCUSSION
176-WITH THE PATIENT
177-.
178-(d) (I) A
179- PHARMACY, CARRIER, OR PHARMACY BENEFIT MANAGER
180-SHALL NOT HAVE A POLICY IN PLACE THAT REQUIRES THE PHARMACIST TO
181-REFUSE TO FILL A PRESCRIPTION FOR AN OPIATE ISSUED BY A HEALTH
182--CARE
183-PROVIDER WITH THE AUTHORITY TO PRESCRIBE OPIATES SOLELY BECAUSE
184-THE PRESCRIPTION IS FOR AN OPIATE OR BECAUSE THE PRESCRIPTION ORDER
185-EXCEEDS A PREDETERMINED MORPHINE MILLIGRAM EQUIVALENT DOSAGE
186-RECOMMENDATION OR THRESHOLD
187-.
169+14
170+PAIN BY PRESCRIBING, DISPENSING, OR ADMINISTERING ONE OR MORE15
171+SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCES THAT INCLUDE , BUT16
172+ARE NOT LIMITED TO, OPIOID ANALGESICS SHALL NOT BE REQUIRED TO17
173+TAPER A PATIENT 'S MEDICATION DOSAGE SOLELY TO MEET A18
174+PREDETERMINED MORPHINE MILLIGRAM EQUIVALENT DOSAGE19
175+RECOMMENDATION OR THRESHOLD IF THE PATIENT IS STABLE AND20
176+COMPLIANT WITH THE TREATMENT PLAN AND IS NOT EXPERIENCING21
177+SERIOUS HARM FROM THE LEVEL OF MEDICATION CURRENTLY BEING22
178+PRESCRIBED OR PREVIOUSLY PRESCRIBED . A DECISION TO TAPER OR23
179+MAINTAIN MEDICATION MUST INCLUDE AN INDIVIDUALIZED ASSESSMENT24
180+OF THE PATIENT'S CURRENT MEDICAL CONDITION AND TREATMENT PLAN ,25
181+THE RISKS AND BENEFITS OF MAINTAINING OR TAPERING THE PATIENT 'S26
182+MEDICATION, AND A DISCUSSION WITH THE PATIENT.27
183+144
184+-5- (d) (I) A PHARMACY, CARRIER, OR PHARMACY BENEFIT MANAGER1
185+SHALL NOT HAVE A POLICY IN PLACE THAT REQUIRES THE PHARMACIST TO2
186+REFUSE TO FILL A PRESCRIPTION FOR AN OPIATE ISSUED BY A HEALTH-CARE3
187+PROVIDER WITH THE AUTHORITY TO PRESCRIBE OPIATES SOLELY BECAUSE4
188+THE PRESCRIPTION IS FOR AN OPIATE OR BECAUSE THE PRESCRIPTION5
189+ORDER EXCEEDS A PREDETERMINED MORPHINE MILLIGRAM EQUIVALENT6
190+DOSAGE RECOMMENDATION OR THRESHOLD .7
188191 (II) A
189- HEALTH-CARE PRACTICE OR CLINIC IN WHICH A HEALTH-CARE
190-PROVIDER IS AUTHORIZED TO PRESCRIBE SCHEDULE
191-II, III, IV, OR V
192-CONTROLLED SUBSTANCES SHALL NOT HAVE A POLICY IN PLACE THAT
193-REQUIRES THE HEALTH
194--CARE PROVIDER TO REFUSE TO PRESCRIBE ,
195-ADMINISTER, OR DISPENSE A PRESCRIPTION FOR AN OPIATE SOLELY BECAUSE
196-THE PRESCRIPTION EXCEEDS A PREDETERMINED MORPHINE MILLIGRAM
197-EQUIVALENT DOSAGE RECOMMENDATION OR THRESHOLD
198-.
199-(e) B
200-EFORE TREATING A PATIENT FOR CHRONIC PAIN IN ACCORDANCE
201-WITH THIS SUBSECTION
202-(3), A HEALTH-CARE PROVIDER SHALL DISCUSS WITH
203-PAGE 4-SENATE BILL 23-144 THE PATIENT OR THE PATIENT'S LEGAL GUARDIAN, IF APPLICABLE, THE RISKS
204-ASSOCIATED WITH THE SCHEDULE
205-II, III, IV, OR V CONTROLLED SUBSTANCE
206-TO BE PRESCRIBED OR ADMINISTERED IN THE COURSE OF THE HEALTH
207--CARE
208-PROVIDER
209-'S TREATMENT OF THE PATIENT AND DOCUMENT THE DISCUSSION
210-IN THE PATIENT
211-'S RECORD.
212-(4) Limits on applicability. (a) T
213-HIS SECTION DOES NOT APPLY TO:
214-(I) A
215- HEALTH-CARE PROVIDER'S TREATMENT OF A PATIENT FOR A
216-SUBSTANCE USE DISORDER RESULTING FROM THE USE OF A SCHEDULE
217-II, III,
192+ HEALTH-CARE PRACTICE OR CLINIC IN WHICH A
193+8
194+HEALTH-CARE PROVIDER IS AUTHORIZED TO PRESCRIBE SCHEDULE II, III,9
218195 IV,
219- OR V CONTROLLED SUBSTANCE;
220-(II) T
221-HE PRESCRIPTION OR ADMINISTRATION OF A SCHEDULE II, III,
222-IV,
223- OR V CONTROLLED SUBSTANCE TO A PATIENT WHOM THE HEALTH -CARE
224-PROVIDER KNOWS TO BE USING THE CONTROLLED SUBSTANCE FOR
225-NONTHERAPEUTIC OR DRUG DIVERSION PURPOSES
226-;
227-(III) T
228-HE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A
229-SCHEDULE
230-II, III, IV, OR V CONTROLLED SUBSTANCE FOR THE PURPOSE OF
231-TERMINATING THE LIFE OF A PATIENT WITH CHRONIC PAIN
232-; OR
233-(IV) THE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A
234-SCHEDULE
235-II, III, IV, OR V CONTROLLED SUBSTANCE THAT IS NOT A
236-CONTROLLED SUBSTANCE APPROVED BY THE FEDERAL FOOD AND DRUG
237-ADMINISTRATION FOR PAIN RELIEF
238-.
239-(b) T
240-HIS SECTION DOES NOT LIMIT THE POWERS AND DUTIES OF THE
241-COLORADO MEDICAL BOARD PURSUANT TO SECTION 12-240-106 OR THE
242-STATE BOARD OF NURSING PURSUANT TO SECTION
243-12-255-107.
244-SECTION 2. Safety clause. The general assembly hereby finds,
245-PAGE 5-SENATE BILL 23-144 determines, and declares that this act is necessary for the immediate
246-preservation of the public peace, health, or safety.
247-____________________________ ____________________________
248-Steve Fenberg
249-Julie McCluskie
250-PRESIDENT OF SPEAKER OF THE HOUSE
251-THE SENATE OF REPRESENTATIVES
252-____________________________ ____________________________
253-Cindi L. Markwell Robin Jones
254-SECRETARY OF CHIEF CLERK OF THE HOUSE
255-THE SENATE OF REPRESENTATIVES
256- APPROVED________________________________________
257- (Date and Time)
258- _________________________________________
259- Jared S. Polis
260- GOVERNOR OF THE STATE OF COLORADO
261-PAGE 6-SENATE BILL 23-144
196+ OR V CONTROLLED SUBSTANCES SHALL NOT HAVE A POLICY IN PLACE
197+10
198+THAT REQUIRES THE HEALTH-CARE PROVIDER TO REFUSE TO PRESCRIBE ,11
199+ADMINISTER, OR DISPENSE A PRESCRIPTION FOR AN OPIATE SOLELY12
200+BECAUSE THE PRESCRIPTION EXCEEDS A PREDETERMINED MORPHINE13
201+MILLIGRAM EQUIVALENT DOSAGE RECOMMENDATION OR THRESHOLD .14
202+(e) BEFORE TREATING A PATIENT FOR CHRONIC PAIN IN15
203+ACCORDANCE WITH THIS SUBSECTION (3), A HEALTH-CARE PROVIDER16
204+SHALL DISCUSS WITH THE PATIENT OR THE PATIENT'S LEGAL GUARDIAN, IF17
205+APPLICABLE, THE RISKS ASSOCIATED WITH THE SCHEDULE II, III, IV, OR V18
206+CONTROLLED SUBSTANCE TO BE PRESCRIBED OR ADMINISTERED IN THE19
207+COURSE OF THE HEALTH-CARE PROVIDER'S TREATMENT OF THE PATIENT20
208+AND DOCUMENT THE DISCUSSION IN THE PATIENT 'S RECORD.21
209+(4) Limits on applicability. (a) THIS SECTION DOES NOT APPLY22
210+TO:23
211+(I) A HEALTH-CARE PROVIDER'S TREATMENT OF A PATIENT FOR A24
212+SUBSTANCE USE DISORDER RESULTING FROM THE USE OF A SCHEDULE II,25
213+III,
214+ IV, OR V CONTROLLED SUBSTANCE;26 (II) THE PRESCRIPTION OR ADMINISTRATION OF A SCHEDULE II, III,27
215+144
216+-6- IV, OR V CONTROLLED SUBSTANCE TO A PATIENT WHOM THE1
217+HEALTH-CARE PROVIDER KNOWS TO BE USING THE CONTROLLED2
218+SUBSTANCE FOR NONTHERAPEUTIC OR DRUG DIVERSION PURPOSES ;3
219+(III) THE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A4
220+SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE FOR THE PURPOSE OF5
221+TERMINATING THE LIFE OF A PATIENT WITH CHRONIC PAIN ; OR6
222+(IV) THE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A7
223+SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE THAT IS NOT A8
224+CONTROLLED SUBSTANCE APPROVED BY THE FEDERAL FOOD AND DRUG9
225+ADMINISTRATION FOR PAIN RELIEF.10
226+(b) THIS SECTION DOES NOT LIMIT THE POWERS AND DUTIES OF THE11
227+COLORADO MEDICAL BOARD PURSUANT TO SECTION 12-240-106 OR THE12
228+STATE BOARD OF NURSING PURSUANT TO SECTION 12-255-107.13
229+SECTION 2. Safety clause. The general assembly hereby finds,14
230+determines, and declares that this act is necessary for the immediate15
231+preservation of the public peace, health, or safety.16
232+144
233+-7-